Department of Viral Immunology;
Helmholtz Centre for Infection Research(HZI);
Braunschweig;
Germany;
Department of Biotechnology;
Institut für Biochemie;
Biotechnologie und Bioinformatik;
Technischen Universität Braunschweig;
Braunschweig;
Germany;
Oxford Vaccine Group;
University of Oxford;
Oxford;
UK;
Center for Proteomics;
University of Rijeka;
Faculty of Medicine;
Rijeka;
Croatia;
Infection Biology Unit;
German Primate Center;
Göttingen;
Germany;
Faculty of Biology and Psychology;
Georg-August-University Göttingen;
Göttingen;
Germany;
Department of Immunology;
Rappaport Faculty of Medicine;
Technion-Israel Institute of Technology;
Haifa;
Israel;
Infection Immunology;
Institute for Medical Microbiology and Hospital Hygiene;
Health Campus Immunology;
Infectiology and Inflammation;
Otto-von-Guericke-University Magdeburg;
Magdeburg;
Germany;
Immune Regulation;
Helmholtz Centre for Infection Research;
Braunschweig;
Germany;
Department of Vaccinology and Applied Microbiology;
Helmholtz Centre for Infection Research;
Braunschweig;
Germany;
Institute of Virology;
Medical University Münster;
Münster;
Germany;
Institute of Virology;
Hannover Medical School(MHH);
Hannover;
Germany;
German Centre for Infection Research(DZIF);
Hannover-Braunschweig Site;
Hannover;
Germany;
Centre for Individualized Infection medicine(CiiM);
a joint venture of HZI and MHH;
Hannover;
Germany;
Vaccine vector; SARS-CoV-2; Influenza; Cytomegalovirus; humoral imunity;